Commonwealth Equity Services, LLC Cocrystal Pharma, Inc. Transaction History

Commonwealth Equity Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.27 - $3.6 $418 - $5,576	-1,549 Reduced 5.83%	25,000 $7,000
Q4 2021 Jan 31, 2022	BUY	$0.65 - $1.02 $6,500 - $10,200	10,000 Added 60.43%	26,549 $17,000
Q3 2021 Oct 29, 2021	BUY	$1.01 - $1.25 $49 - $61	49 Added 0.3%	16,549 $17,000
Q2 2021 Aug 11, 2021	BUY	$1.08 - $2.14 $5,400 - $10,700	5,000 Added 43.48%	16,500 $20,000
Q1 2021 May 04, 2021	SELL	$1.3 - $2.35 $6,500 - $11,750	-5,000 Reduced 30.3%	11,500 $15,000
Q4 2020 Feb 11, 2021	BUY	$0.8 - $2.16 $13,200 - $35,640	16,500 New	16,500 $22,000
Q2 2020 Aug 12, 2020	SELL	$0.7 - $1.58 $7,000 - $15,800	-10,000 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$0.48 - $2.19 $4,800 - $21,900	10,000 New	10,000 $7,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.5M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.